Pantorise - P40 (Pantoprazole 40 mg) is a potent gastroprotective agent designed to provide 24-hour coverage against gastric acid-related conditions. Superior to ranitidine and famotidine, it effectively reduces stomach acid production, promoting healing and comfort in conditions such as acute gastritis, acid reflux, chronic and peptic ulcers, and for pre- and post-surgical care.
Its tailored dosage of 0.7-1 mg/kg once daily allows for flexible administration either intravenously or subcutaneously, ensuring precise and efficient treatment for optimal results.
Acute gastritis
Acid reflux
Chronic ulcer
Peptic ulcer
Pre & post surgery
Should be given 0.7-0.1 mg/kg once daily it can be given intravenously or subcutaneously.
Pantorise - P40 is available in three variations—Pantorise - P40 Injection, Pantorise - P40 Tablets (10110), and Pantorise - PD Tablets (10110)—each catering to specific treatment needs for enhanced flexibility in gastroprotective care.
The injection form is ideal for emergency or hospitalized cases where immediate relief is required, ensuring rapid absorption and effectiveness. The Pantorise - P40 Tablets provide a reliable oral solution for daily management of chronic conditions like gastritis and ulcers. Meanwhile, the Pantorise - PD Tablets, designed for easier dosage adjustments, are suited for pets needing a tailored approach to therapy.
These variations enable veterinarians and pet owners to choose the most effective and convenient format, ensuring comprehensive care for gastrointestinal conditions.
Scientific Insight: Pantorise - P40 provides long-lasting acid suppression due to its mechanism of action as a proton pump inhibitor (PPI). It blocks the final step in gastric acid production by irreversibly inhibiting the H+/K+ ATPase enzyme system in stomach lining cells.
Benefit: This ensures effective control of acid reflux and ulcers, delivering continuous relief and healing throughout the day with just a single dose.
Scientific Insight: Unlike ranitidine or famotidine, Pantoprazole offers a more potent and sustained reduction in gastric acid secretion. It does not develop tolerance with prolonged use, maintaining its effectiveness even in chronic cases.
Benefit: This superiority makes Pantorise - P40 a reliable choice for managing chronic gastritis, peptic ulcers, and acid reflux in pets.
Scientific Insight: Pantorise - P40 is formulated for both intravenous and oral administration, ensuring therapeutic flexibility. The IV option allows rapid action in acute cases, while the tablet form ensures ease of administration for long-term therapy.
Benefit: This adaptability makes Pantorise - P40 suitable for diverse clinical scenarios, whether immediate relief or ongoing management is required.
Q
What is Pantorise - P40 used for?
A
Pantorise - P40 is a gastroprotective agent used to treat conditions like acute gastritis, acid reflux, chronic ulcers, peptic ulcers, and pre- or post-surgery-related gastric issues in pets. It provides 24-hour acid suppression for effective relief and healing.
Q
How is Pantorise - P40 different from other acid reflux medications?
A
Pantorise - P40 is a proton pump inhibitor (PPI) that offers superior acid suppression compared to H2 receptor antagonists like ranitidine or famotidine. It provides sustained 24-hour relief, does not lose effectiveness with prolonged use, and is available in both injectable and tablet forms for versatile treatment options.
Q
Is Pantorise - P40 safe for long-term use in pets?
A
Yes, Pantorise - P40 is safe for long-term use under veterinary guidance. Its specific action on gastric acid production ensures effective management of chronic conditions without the risk of developing tolerance, making it an ideal choice for ongoing care.
